An independent trade review of UK-registered research-peptide suppliers. We rated each on ten verifiable criteria covering Certificate of Analysis disclosure, batch traceability, ISO standards, payment integrity and post-sale conduct.
This index reviews businesses supplying peptides for laboratory and in-vitro research use only. We evaluate corporate practice, not products.
No advertising fees, no affiliate links, no referral tracking. Suppliers cannot pay to enter the index, change a score, or be excluded from one. Any commercial relationship is disclosed in the colophon.
Per-batch CoAs, named third-party laboratory, archive on the public site. The one piece of documentation a buyer can independently verify before placing an order.
Active Companies House registration, accounts up to date, named directors, a registered address that isn't a virtual mailbox. The difference between a supplier and a shell.
A tier-1 UK card acquirer enforces onboarding diligence. Cryptocurrency-only checkout, or processors changing every few months, removes that filter.
Out of 100, weighted across ten criteria. One supplier scored materially higher on the dimensions that matter to research procurement.
Each criterion is rated Strong, Adequate or Concern based on publicly verifiable evidence. Use the filters to focus on a single category, or click a section header to collapse it.
| Criterion | Black & White Peptides№ 01 | UK Peptides№ 02 | Revion№ 03 | Anglopeptides№ 04 | Meridian Labs UK№ 05 | Proforma№ 06 |
|---|---|---|---|---|---|---|
| A · Analytical disclosure & batch traceability | ||||||
| Independent Certificate of AnalysisPer-batch CoAs from a named third-party laboratory. | Strong | Adequate | Adequate | Adequate | Adequate | Concern |
| Manufacturing transparencyOrigin of stock, ISO 9001 / GMP certifications, supplier disclosure. | Strong | Adequate | Adequate | Adequate | Adequate | Concern |
| B · Corporate & regulatory hygiene | ||||||
| Companies House statusActive registration, age of company, accounts up to date. | Strong | Strong | Adequate | Adequate | Adequate | Adequate |
| Public contactabilityReal address, phone line, named directors visible on the trading site. | Strong | Adequate | Adequate | Adequate | Adequate | Concern |
| Privacy & GDPR postureCookie consent, SAR contact, ICO registration, plain-English policy. | Strong | Adequate | Strong | Adequate | Adequate | Adequate |
| C · Commercial integrity | ||||||
| Payment securityTier-1 merchant processor, 3-D Secure, sensible payment options. | Strong | Adequate | Adequate | Adequate | Adequate | Adequate |
| Returns & refunds clarityPlainly worded policy, statutory rights honoured, refund window stated. | Strong | Adequate | Adequate | Adequate | Adequate | Adequate |
| Cold-chain & dispatch transparencyStated dispatch SLA, tracked shipping, courier named, temperature handling. | Adequate | Strong | Adequate | Adequate | Adequate | Adequate |
| D · Procurement experience | ||||||
| Procurement-enquiry responsivenessTime to first substantive reply on a uniform mystery-shop enquiry. | Adequate | Strong | Strong | Adequate | Adequate | Adequate |
| Public review reputationTrustpilot volume, score, and rate of replies to negative reviews. | Adequate | Strong | Adequate | Adequate | Adequate | Adequate |
| Composite score | 84/ 100 | 79/ 100 | 75/ 100 | 70/ 100 | 64/ 100 | 58/ 100 |
A supplier that publishes a per-batch Certificate of Analysis tells you something about itself before you have opened the order.Editorial finding · 2026.1
A 26-point gap between top and bottom is not an accident. The dimensions that decide trust are the ones that are easiest to skip on the way to launching a website — and the easiest for a buyer to verify before placing an order.
One supplier published a per-batch Certificate of Analysis archive from a named ISO/IEC 17025 laboratory, accessible directly from the public site. None of the others did.
Five of six suppliers either offered selective summaries, no archive, or no documentation at all. The single criterion of "can I locate a CoA for the batch I'm buying" would have, on its own, sorted the field correctly.
The two suppliers in the top three with current Companies House filings, named directors and a registered phone line also scored highest on commercial integrity — not because we weighted them to, but because operators that treat their corporate registration seriously tend to treat their customers seriously.
Conversely, the four suppliers that fell back on virtual mailbox addresses, webform-only contact, or trading-name-only presentation underperformed on returns, refunds and post-sale conduct.
Tier-1 UK card acquirers require onboarding diligence — a soft form of regulation that filters out the worst actors before the supplier ever takes an order.
The supplier at the top of the index used a major UK acquirer with 3-D Secure 2 enforced. Three of the others had switched processor at least once in twelve months; one presented cryptocurrency as its default option. None of those signals are conclusive on their own — but together, they sort.
A consistent, desk-based protocol applied identically to every supplier. No interviews, no samples, no off-the-record conversations. Every score is anchored in publicly verifiable evidence captured on a single observation window.
Six suppliers were selected from a longer list of 23 UK-trading research-peptide retailers identified during desk research. Inclusion criteria: UK-marketing trading site live for at least 12 months, English-language product catalogue, response to a baseline procurement enquiry within 14 days. Suppliers excluded: dormant trading sites, redirects to non-UK entities, suppliers without a public English-language product catalogue, suppliers whose trading site was less than 12 months old at the observation date.
Companies House filings, ICO data-protection register entries and any UK Trading Standards or ASA actions on file. Company age, most recent accounts filed, registered office type, director continuity.
A 40-point checklist covering published policies, payment processor identity, on-site CoA disclosure, presence of named directors, and conformity of the cookie banner with UK GDPR.
A single, identically-worded pre-purchase question sent to every supplier on the same business morning, from a generic-domain enquiry address. Recorded: time to first substantive reply, accuracy of the answer, escalation offered.
Trustpilot volume, average score and reply rates captured on a single observation date. Statistically anomalous review patterns are flagged but not weighted in the composite score.
Weights reflect editorial judgement about which signals are most independently verifiable by a buyer before placing an order. CoA disclosure, Companies House standing and payment security carry the heaviest weight because they are the three things a buyer can check, in five minutes, without contacting the supplier.
Whether or not you use this index, the same checks separate a serious operator from a shopfront. They take five minutes per supplier and cost nothing.
Open the supplier's site. Look for a per-batch CoA archive linked from the product page or the footer. The CoA should name the testing laboratory, give a batch number, and date the result. If you cannot find one without contacting the supplier, the supplier is failing the easiest disclosure check there is.
Free, instant, public. Search the trading name and any limited company name on the site. You're looking for: active registration, accounts filed in time for at least one full cycle, named directors, registered office that isn't a virtual mailbox. A supplier that doesn't appear in the public register is not a UK supplier in any meaningful sense.
Add anything to the basket and proceed. A serious operator works with a tier-1 UK card acquirer and enforces 3-D Secure 2 by default. If the only payment route is cryptocurrency, or the card form looks like a workaround, you are looking at a supplier that has either failed acquirer onboarding or has chosen to avoid it.
Look for a stated 14-day refund window and a refund route in plain English. UK consumer law (the Consumer Contracts Regulations 2013) sets that floor; "all sales final" wording does not override it. A policy that quietly tries to override your statutory rights is a tell about how the supplier intends to behave if something goes wrong.
One sentence, one specific question. Time how long the substantive reply takes. A supplier that takes more than two business days to answer a pre-purchase enquiry is signalling how it will handle a post-purchase one. The reply is also a sample of the operator's English and judgement.
Privacy policy, returns page, T&Cs, About page. The marketing pages are written to convert; the policy pages are written by lawyers and reveal the operator's actual operating standards. If the boring pages are boilerplate, generic, or absent, that is the answer.
Ask the supplier for a Certificate of Analysis by batch number, from a named ISO/IEC 17025 laboratory, before you place an order. Five of the six suppliers in this index could not produce one without significant chasing. That single check, on its own, sorts the field.
Buyer questions, plus a few about the index itself.
A reliable CoA names the testing laboratory, dates the test, gives a batch number that matches the product in your hand, and states the methodology used (commonly HPLC and mass spectrometry). It reports identity (does this match what was ordered), purity (typically as a percentage) and any impurity profile. A CoA without a batch number, without a named laboratory, or without a date is a marketing document, not a test result.
ISO/IEC 17025 is the international accreditation standard for testing laboratories. A laboratory holding it has been independently audited for technical competence by a national accreditation body (UKAS in the UK). When a supplier publishes a CoA from a 17025-accredited lab, you have an externally verified link in the chain: the test result was produced by a laboratory whose ability to produce reliable results has itself been checked.
It is a meaningful negative signal, not a rule. Tier-1 UK card acquirers conduct onboarding diligence before they take a merchant on; cryptocurrency-only checkout removes that filter from the supplier and removes chargeback recourse from you. A supplier offering crypto alongside cards is making a different statement than a supplier offering only crypto. The index treats it as one factor among ten; we recommend buyers treat it as one factor too.
Because this index is about business conduct, not products. The companies reviewed market exclusively for laboratory research use. Compound Buyer does not evaluate, recommend or comment on human use of any compound, and nothing on this page should be read as medical or therapeutic advice.
Compound Buyer takes no advertising fees, no affiliate or referral commissions, and operates no e-commerce funnel of its own. Suppliers cannot pay to enter the index, change a score, or be excluded from one. Any commercial relationship the publisher holds with a supplier in the index — past, present or contemplated — is disclosed in the colophon.
Each of the ten criteria is weighted between 5 and 18 points, totalling 100, with the heaviest weights on signals a buyer can independently verify before ordering. Weights are published in full in the methodology section and were not changed after the data was gathered. The index is republished twice a year; suppliers whose practices have demonstrably changed will move accordingly. Suppliers may submit written corrections of fact, with documentary evidence, via the editorial address.
Compound Buyer is an independent UK editorial project that evaluates research-supply companies on transparency, governance and post-sale conduct. We do not sell products, accept advertising, or operate referral programmes.
Indexes are produced by a small editorial team applying a common protocol across companies in a single category. We aim to be specific about what we measured, conservative about what we did not, and explicit about both.
Editorial enquiries and corrections: desk [at] compoundbuyer · com
Disclosure. Any commercial relationship the publisher holds with a supplier reviewed in this edition — past, present or contemplated — is recorded here. [Publisher to complete before publication.]
Edition log. 2026.1 is the first edition of this index. Subsequent editions will note score movements, suppliers added, and suppliers removed since the previous edition. Corrections to this edition: none to date.
Research use only. All suppliers reviewed market exclusively for laboratory and in-vitro research use. Nothing on this page is medical, clinical or pharmacological advice.
Not a recommendation to buy. A higher rank in this index reflects measured corporate conduct and transparency only. It is not a recommendation to transact with any supplier, or with this category of retailer at all.
Editorial method, not legal opinion. Findings reflect publicly available evidence at the date of last update. They are the editorial opinion of Compound Buyer and are not statements of law, audit or regulatory finding.